Inventor
SAXTY GORDON
GB42 patents
⚠️ This page may combine multiple inventors who share the name “SAXTY GORDON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
24 patentsUS9447098B2Sep 20, 2016
Pteridines as FGFR inhibitors
ASTEX THERAPEUTICS LTD35 citations94
US9309242B2Apr 12, 2016
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD26 citations94
US9303029B2Apr 5, 2016
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD25 citations94
US9464071B2Oct 11, 2016
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD24 citations93
US9439896B2Sep 13, 2016
Quinolines as FGFR kinase modulators
ASTEX THERAPEUTICS LTD22 citations92
US9850228B2Dec 26, 2017
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD17 citations91
US9783538B2Oct 10, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD12 citations91
US10052320B2Aug 21, 2018
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD11 citations84
US10045982B2Aug 14, 2018
Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD11 citations84
US10039759B2Aug 7, 2018
Quinolines as FGFR kinase modulators
ASTEX THERAPEUTICS LTD11 citations84
US10618895B2Apr 14, 2020
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD4 citations83
US10519137B2Dec 31, 2019
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD6 citations83
US9856236B2Jan 2, 2018
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD16 citations83
US9617283B2Apr 11, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD10 citations83
US9617248B2Apr 11, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD10 citations83
US9663512B2May 30, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD8 citations82
US10272087B2Apr 30, 2019
Pteridines as FGFR inhibitors
ASTEX THERAPEUTICS LTD5 citations73
US11643410B2May 9, 2023
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD1 citations72
US11225476B2Jan 18, 2022
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD3 citations72
US9980973B2May 29, 2018
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD6 citations71
US12202828B2Jan 21, 2025
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD0 citations62
US9006430B2Apr 14, 2015
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein
ASTEX THERAPEUTICS LTD2 citations61
US8809336B2Aug 19, 2014
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
ASTEX THERAPEUTICS LTD2 citations61
US9283226B2Mar 15, 2016
Pyrazole derivatives as protein kinase modulators
ASTEX THERAPEUTICS LTD0 citations50
SAXTY GORDON
9 patentsUS9290478B2Mar 22, 2016
Substituted quinoxalines as FGFR kinase inhibitors
SAXTY GORDON25 citations93
US8895601B2Nov 25, 2014
Pyrazolyl quinoxaline kinase inhibitors
SAXTY GORDON25 citations91
US8859582B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON7 citations83
US8131527B1Mar 6, 2012
FGFR pharmacophore compounds
SAXTY GORDON17 citations83
US8076354B2Dec 13, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON9 citations83
US8071614B2Dec 6, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON16 citations83
US8481531B2Jul 9, 2013
Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use
SAXTY GORDON9 citations82
US8859583B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON0 citations51
US8722687B2May 13, 2014
Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
SAXTY GORDON0 citations38
BERDINI VALERIO
6 patentsUS8895745B2Nov 25, 2014
Bicyclic heterocyclic compounds as FGFR inhibitors
BERDINI VALERIO33 citations92
US8513276B2Aug 20, 2013
Imidazo[1,2-a]pyridine compounds for use in treating cancer
BERDINI VALERIO8 citations82
US8247576B2Aug 21, 2012
Pyrazole derivatives as protein kinase modulators
BERDINI VALERIO5 citations71
US8546407B2Oct 1, 2013
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
BERDINI VALERIO4 citations61
US8691806B2Apr 8, 2014
Pyrazole derivatives as protein kinase modulators
BERDINI VALERIO2 citations60
US8796244B2Aug 5, 2014
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
BERDINI VALERIO2 citations50